RZH
APLT

Relyea Zuckerberg Hanson’s Applied Therapeutics APLT Stock Holding History

Relyea Zuckerberg Hanson’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-40,000
Closed -$272K – 236
2024
Q1 		$272K Hold
40,000
– – 0.05% 189
2023
Q4 		$134K Hold
40,000
– – 0.03% 224
2023
Q3 		$99.6K Buy
+40,000
New +$65.9K 0.02% 189

Other funds holding APLT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Relyea Zuckerberg Hanson's APLT Position: Q2 2024 in Review

Relyea Zuckerberg Hanson sold out of Applied Therapeutics (APLT) in Q2 2024, closing a stake of 40,000 shares — an estimated $272K sold.

Relyea Zuckerberg Hanson first reported a position in APLT in Q3 2023 and held it in 3 quarters. The position peaked at $272K in Q1 2024. 94 funds tracked by Wall St. Rank hold APLT as of Q2 2024.

  • Relyea Zuckerberg Hanson reported no remaining Applied Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Relyea Zuckerberg Hanson sold 40,000 Applied Therapeutics shares in Q2 2024, an estimated $272K.
  • Relyea Zuckerberg Hanson first reported a position in Applied Therapeutics in Q3 2023 and held it in 3 quarters.
  • Relyea Zuckerberg Hanson's Applied Therapeutics position peaked at $272K in Q1 2024.
  • 94 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2024.

Based on Relyea Zuckerberg Hanson's 13F filing for Q2 2024, filed 17 Jul 2024.